SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-020670
Filing Date
2020-08-06
Accepted
2020-08-06 16:55:12
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_aikidopharmainc.htm 10-Q 565341
2 CERTIFICATION f10q0620ex31-1_aikidopharma.htm EX-31.1 12104
3 CERTIFICATION f10q0620ex32-1_aikidopharma.htm EX-32.1 4872
  Complete submission text file 0001213900-20-020670.txt   2275224

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE aiki-20200630.xml EX-101.INS 287032
5 XBRL SCHEMA FILE aiki-20200630.xsd EX-101.SCH 42151
6 XBRL CALCULATION FILE aiki-20200630_cal.xml EX-101.CAL 35873
7 XBRL DEFINITION FILE aiki-20200630_def.xml EX-101.DEF 101791
8 XBRL LABEL FILE aiki-20200630_lab.xml EX-101.LAB 238981
9 XBRL PRESENTATION FILE aiki-20200630_pre.xml EX-101.PRE 162904
Mailing Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA, 11TH FLOOR NEW YORK NY 10020 347-321-7646
Aikido Pharma Inc. (Filer) CIK: 0000012239 (see all company filings)

IRS No.: 520849320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-05576 | Film No.: 201082485
SIC: 8731 Services-Commercial Physical & Biological Research